Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenol vs Silver Nitrate for Pilonidal Sinus
NCT04560049Phase 4Completed
- Sponsor
- Umraniye Education and Research Hospital
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of silver nitrate in pilonidal sinus (2 arms), sponsored by Umraniye Education and Research Hospital. Primary endpoint: Healing of the pilonidal sinus disease at 8 weeks. Started Jun 2020; status: completed.
02
Drugs
silver nitrate
03
Conditions
pilonidal sinus
Beyond the preview
Go deeper on NCT04560049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04560049.